Skip to main content
Clinical Trials/JPRN-UMIN000020194
JPRN-UMIN000020194
Completed
未知

An observational study for incidence of thromboembolism in lung cancer patients, and the evaluation for efficacy and safety of edoxaban in active cancer patients with venous thromboembolism - An observational study for incidence of thromboembolism in lung cancer patients

Shimane University Faculty of Medicine0 sites1,025 target enrollmentJanuary 31, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
on-small cell lung cancer, small cell lung cancer
Sponsor
Shimane University Faculty of Medicine
Enrollment
1025
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 31, 2016
End Date
August 13, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Shimane University Faculty of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • History of allergic reaction for edoxavan Severe renal dysfunction (Ccr under 30 mL/min) Severe liver disease Interstitial pneumonia Plannning for concurrent chemoradiotherapy Started medication or treatment for VTE Active bleeding Severe hypertention A pregnant woman, a woman in breast\-feeding Taking aspirin or two kind os antiplatelet drug Acute infectious endocarditis An inappropriate case judged by doctor in charge

Outcomes

Primary Outcomes

Not specified

Similar Trials